Gemigliptin tartrate|1374639-74-3|(LC15-0444 tartrate)-陌孚医药/Medlife

您当前的位置：

Gemigliptin tartrate (Synonyms: LC15-0444 tartrate)

目录号: PL11613 纯度: ≥98%

CAS No. :1374639-74-3

商品编号	规格	价格	会员价
PL11613-10mg	10mg	¥1360.00	请登录
PL11613-50mg	50mg	¥4080.00	请登录
PL11613-100mg	100mg	¥6429.09	请登录
PL11613-200mg	200mg	询价	询价
PL11613-500mg	500mg	询价	询价
PL11613-10mM*1mLinDMSO	10mM*1mLinDMSO	¥1496.00	请登录

Medlife所售产品仅用于科学研究（非临床研究），非药品不可食用，不可用于人体或动物的临床诊断和治疗，我们不为个人提供产品及服务。产品COA等资料，可至下方“质量控制”中下载。

加入购物车在线咨询收藏产品大包装询价

中文名称	Gemigliptin tartrate
中文别名	吉格列汀酒石酸盐
英文名称	Gemigliptin tartrate
英文别名	LC15-0444 tartrate;Gemigliptin tartrate;Gemigliptin (tartrate);Gemigliptin (2R,3R)-2,3-dihydroxybutanedioate;Gemigliptin (2R,3R)-2,3-dihydroxybutanedioate;Gemigliptin (2R,3R)-2,3-ihydroxybutanedioat;1-[(2S)-2-amino-4-[2,4-bis(trifluoromethyl)-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-7-yl]-4-oxobutyl]-5,5-difluoropiperidin-2-one;(2R,3R)-2,3-dihydroxybutanedioic acid
Cas No.	1374639-74-3
分子式	C₂₂H₂₅F₈N₅O₈
分子量	639.45
包装储存	4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

产品详情

Gemigliptin tartrate (LC15-0444 tartrate) 是一种高度选择性的，可逆的，竞争性的二肽基肽酶 4 (DPP-4) 抑制剂，对人重组 DPP-4 作用的 IC₅₀ 值为 10.3 nM。Gemigliptin tartrate 具有很强的抗糖基化特性。Gemigliptin tartrate 可用于晚期糖基化终产物 (AGE) 相关的糖尿病并发症的研究。

生物活性

Gemigliptin tartrate (LC15-0444 tartrate) is a highly selective, reversible and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor, with an IC 50 of 10.3 nM for human recombinant DPP-4. Gemigliptin tartrate exhibits potent anti-glycation properties. Gemigliptin tartrate can be used for the research of advanced glycation end products (AGE)-related diabetic complications.

性状

Solid

IC50 & Target[1][2]

IC50: 10.3 nM (human recombinant DPP-4)

体外研究(In Vitro)

Gemigliptin tartrate dose-dependently inhibits the formation of AGE-BSA with IC50 of 11.69 mM.
Gemigliptin tartrate dose-dependently suppresses the cross-linking of preformed AGE-BSA with rat tail tendon collagen with an IC50 of 1.39 mM.
Gemigliptin tartrate is a competitive DPP-4 inhibitor with a Ki of 7.25 nM.
has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究(In Vivo)

Gemigliptin tartrate (100 mg/kg; i.g.; daily; for 12 weeks) inhibits AGEs formation and AGE cross-links in vivo.
Gemigliptin tartrate dose-dependently inhibits plasma DPP-4 activity in rats, dogs, and monkeys.
has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model:

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

ClinicalTrial

参考文献

[1]. Jung E, et al. Gemigliptin, a novel dipeptidyl peptidase-4 inhibitor, exhibits potent anti-glycation properties in vitro and in vivo. Eur J Pharmacol. 2014 Dec 5;744:98-102.
[2]. Kim SH, et al. Pharmacological profiles of gemigliptin (LC15-0444), a novel dipeptidyl peptidase-4 inhibitor, in vitro and in vivo. Eur J Pharmacol. 2016 Oct 5;788:54-64.

溶解度数据	In Vitro: DMSO : 100 mg/mL (156.38 mM; Need ultrasonic)配制储备液

搜索质检报告(COA)

产品使用指南

Data Sheet

1：一般建议：溶解度为Medlife测试数据，可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解，请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异，仅做参考，具体以实验方案为准。

2：储存条件：粉末-20°C一般情况可以保存3年，溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异，请细致阅读产品信息，并辅助参考相关文献描述。

相关产品

The molarity calculator equation

The dilution calculator equation